Table 1. Description of included studies

U, upper gastrointestinal tract; L, lower gastrointestinal tract; NA, not applicable; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; RP, radiation proctopathy; O, oozing; S, spurting; GDU, gastro-duodenal ulcer; ERCP, endoscopic retrograde cholangiopancreatography; AMP, ampullectomy.

Table 2. Summary of primary outcomes of self-assembling peptide for active bleeding

NA, not applicable.

Table 3. Summary of primary outcomes of self-assembling peptide for prophylaxis

EMR, endoscopic mucosal resection; AMP, ampullectomy; ESD, endoscopic submucosal dissection; RP, radiation proctopathy; NA, not applicable.

Table 4. Summary of outcomes according to use of associated treatments

NA, not applicable.

Table 5. Methodological index for non-randomized studies Table 6. The modified Jadad scale for randomized controlled trial studies